Article ID Journal Published Year Pages File Type
4029210 Ophthalmology 2007 7 Pages PDF
Abstract
Short-term results indicate that inhibition of vascular endothelial growth factor by intravitreal bevacizumab is associated with a decrease in retinal thickness and a reduction in angiographic leakage in type 2 IMT. Furthermore, intravitreal bevacizumab may improve VA in affected patients.
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Authors
, , , ,